RNS
CELG

Robert N. Shapiro’s Celgene Corp CELG Stock Holding History

Robert N. Shapiro’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$611K Buy
5,461
+205
+4% +$21.6K 0.12% 158
2014
Q3 		$498K Sell
5,256
-1,476
-22% -$133K 0.09% 179
2014
Q2 		$578K Sell
6,732
-700
-9% -$53.2K 0.11% 167
2014
Q1 		$520K Sell
7,432
-310
-4% -$24.5K 0.1% 178
2013
Q4 		$654K Sell
7,742
-4,418
-36% -$350K 0.12% 153
2013
Q3 		$937K Buy
12,160
+2,440
+25% +$171K 0.17% 140
2013
Q2 		$568K Buy
+9,720
New +$585K 0.12% 156

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Robert N. Shapiro's CELG Position: Q4 2014 in Review

Robert N. Shapiro increased its Celgene Corp (CELG) stake by 3.9% in Q4 2014, buying an estimated $21.6K and bringing the position to 5,461 shares worth $611K. The position accounts for 0.12% of the portfolio, ranked #158.

Robert N. Shapiro first reported a position in CELG in Q2 2013 and has held it in 7 quarters since. The position peaked at $937K in Q3 2013. 1,161 funds tracked by Wall St. Rank hold CELG as of Q4 2014.

  • Robert N. Shapiro held 5,461 shares of Celgene Corp worth $611K as of Q4 2014.
  • Robert N. Shapiro bought 205 Celgene Corp shares in Q4 2014, an estimated $21.6K.
  • Celgene Corp made up 0.12% of Robert N. Shapiro's portfolio in Q4 2014, its #158 holding.
  • Robert N. Shapiro first reported a position in Celgene Corp in Q2 2013 and has held it in 7 quarters since.
  • Robert N. Shapiro's Celgene Corp position peaked at $937K in Q3 2013.
  • 1,161 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.